CÁNCER DE MAMA
![Foto de CÁNCER DE MAMA](/img/grupo.png)
![Foto de Ikerbasque, Fundación Vasca para la Ciencia](/img/noimage_org.png)
Ikerbasque, Fundación Vasca para la Ciencia
Bilbao, EspañaPublicaciones en colaboración con investigadores/as de Ikerbasque, Fundación Vasca para la Ciencia (12)
2024
-
A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer
Breast Cancer Research, Vol. 26, Núm. 1
-
Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant eR+ breast cancer
Science Translational Medicine, Vol. 16, Núm. 736
2023
-
Diffuse large B-cell lymphoma microenvironment displays a predominant macrophage infiltrate marked by a strong inflammatory signature
Frontiers in Immunology, Vol. 14
-
Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer
Nature Communications, Vol. 14, Núm. 1
-
New perspectives in cancer immunotherapy: targeting IL-6 cytokine family
Journal for immunotherapy of cancer, Vol. 11, Núm. 11
2022
-
Extracellular vesicles from thyroid cancer harbor a functional machinery involved in extracellular matrix remodeling
European Journal of Cell Biology, Vol. 101, Núm. 3
-
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
Journal of Clinical Investigation, Vol. 132, Núm. 7
2021
-
Discovery and proof-of-concept study of nuclease activity as a novel biomarker for breast cancer tumors
Cancers, Vol. 13, Núm. 2, pp. 1-16
-
The pseudokinase TRIB3 negatively regulates the HER2 receptor pathway and is a biomarker of good prognosis in luminal breast cancer
Cancers, Vol. 13, Núm. 21
-
The role of the il-6 cytokine family in epithelial–mesenchymal plasticity in cancer progression
International Journal of Molecular Sciences, Vol. 22, Núm. 15
2020
-
The urinary transcriptome as a source of biomarkers for prostate cancer
Cancers, Vol. 12, Núm. 2